Cary Street Partners Investment Advisory’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.1K | Buy |
|
|||||
|
2025
Q1 | $39.3K | Buy |
|
|||||
|
2024
Q4 | $5.48K | Sell |
|
|||||
|
2024
Q3 | $286K | Sell |
|
|||||
|
2024
Q2 | $285K | Buy |
|
|||||
|
2024
Q1 | $217K | Sell |
|
|||||
|
2023
Q4 | $207K | Hold |
|
|||||
|
2023
Q3 | $202K | Buy |
|
|||||
|
2023
Q2 | $170K | Sell |
|
|||||
|
2023
Q1 | $176K | Sell |
|
|||||
|
2022
Q4 | $189K | Sell |
|
|||||
|
2022
Q3 | $183K | Buy |
|
|||||
|
2022
Q2 | $267K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $411K | Buy |
|
|||||
|
2020
Q3 | $159K | Buy |
|